http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2784845-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62bf2c8e3be7f282db6e658eb393bed1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0031
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
filingDate 2010-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ea7a59c2587aa4c7dfc66024e73675b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af7f013976e9299fd2ed3725fa0c32e7
publicationDate 2011-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2784845-A1
titleOfInvention Use of maltodextrin in the treatment of stress, anxiety and depressive behaviours
abstract The present invention relates to a composition comprising a mixture of a polysaccharide having: - between 15 and 50% glucoside bonds 1-6; a reducing sugar content of less than 20%; a polymolecularity index of less than 5; a number average molecular weight Mn of less than 4500 g / mol and at least one active agent for the treatment of stress, anxiety or depressive behavior, sleep disorders, obsessive-compulsive disorders, bulimia, and epilepsy in humans or animals. The present invention also relates to a use of this polysaccharide for the treatment of stress, anxiety or depressive behaviors, sleep disorders, obsessive-compulsive disorders, bulimia, and epilepsy in humans. or the animal.
priorityDate 2009-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419549034
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19643
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49253
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ556K4
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ556K3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54IT3
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP56560
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21398
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21397
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3016
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21396
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ64133
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP46882
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6NSN2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO18851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533724
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8BW75

Total number of triples: 51.